Molecular docking and preclinical studies of Gymnema sylvestre on endothelial nitric oxide synthase in Type-2 diabetes-related complications

Journal of Young Pharmacists

Volumn 6, Issue 4, 2014, Pages 25-32

  Khan, K Abedulla ^a   Dobani, Shabnam ^a   Shareef, Mohammed Adil ^a  

^a SULTAN UL ULOOM COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes and diabetic vascular complications; Endothelial nitric oxide synthase; Gymnema sylvestsre; Molecular docking

Indexed keywords

ACETYLCHOLINE; BRADYKININ; DEACYLGYMNEMIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; GYMNEMAGENIN; GYMNEMASAPONIN I; GYMNEMASAPONIN II; GYMNEMASAPONIN III; GYMNEMASAPONIN IV; GYMNEMASAPONIN V; GYMNEMIC ACID; GYMNEMOSIDE A; GYMNEMOSIDE B; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DETERMINATION; DRUG EFFECT; DRUG TARGETING; GLUCOSE BLOOD LEVEL; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PLANT LEAF; RAT;

EID: 84923610189     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.5530/jyp.2014.4.5     Document Type: Article

References (18)

1. Rother KI. Diabetes treatment - Bridging the divide. N Engl J Med. 2007;356:1499-501.
2. Turko IV, Marcondes S, Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA: 3-oxoacid Co A-transferase. Am J Physiol Heart Circ Physiol. 2001;281:H2289-94.
3. Ogonowski AA, Kaesemeyer WH, Jin L, Ganapathy V, Leibach FH, Caldwell R W. Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production. Am J Physiol Cell Physiol. 2000;278:C136-43.
4. Altaha R, Fojo T, Reed E, Abraham J. Epothilones: A novel class of non-taxane microtubule-stabilizing agents. Curr Pharm Des. 2002;8:1707-12.
5. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov. 2004;3:935-49.
6. Sikarwar MS, Patil MB, Kokate CK, Sharma S, Bhat V. Antidiabetic activity of Nerium indicum leaf extract in alloxan-induced diabetic rats. J Young Pharm. 2009;1:340-5.
7. Al-Romaiyan A, Liu B, Asare-Anane H, Maity CR, Chatterjee SK, Koley N, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010;24:1370-6.
8. Kumar G, Mishra PK, Prakash V. Antidiabetic and hypolipidemic activity of Gymnema sylvestre in alloxan induced diabetic rats. Glob J Biotechnol Biochem. 2009;4:37-42.
9. Altaha R, Fojo T, Reed E, Abraham J. Epothilones: A novel class of non-taxane microtubule-stabilizing agents. Curr Pharm Des. 2002;8:1707-12.
10. Heikkila RE. The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur J Pharmacol. 1977;44:191-3.
11. Ghosh MN. Fundamentals of Experimental Pharmacology. Vol. 2. Kolkata: Scientific Book Agency; 1984. p. 15-6.
12. Miles AM, Wink DA, Cook JC, Grisham MB. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol. 1996; 268: 105-20.
13. Wagner KH, Elmadfa I. Biological relevance of gymnemins-overview focusing on acids. Ann Nutr Metab. 2003;47:95-106.
14. Kuroda C, Suzuki H. Synthesis of odd-membered rings by the reaction of beta-carbonylallylsilane or its derivative as a carbon 1, 3-dipole. Curr Org Chem. 2003;7:115-31.
15. Ridley RG. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature. 2002;415:686-93.
16. Abdin MZ, Israr M, Rehman RU, Jain SK. Artemisinin, a novel antimalarial drug: Biochemical and molecular approaches for enhanced production. Planta Med. 2003;69:289-99.
17. Abebe W. Herbal medication: Potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27:391-401.
18. Kang MH, Lee MS, Choi MK, Min KS, Shibamoto T. Hypoglycemic activity of Gymnema sylvestre extracts on oxidative stress and antioxidant status in diabetic rats. J Agric Food Chem. 2012;60:2517-24.